Results 101 to 110 of about 105,256 (302)

The Association Between Muscle Health and Quality of Life in Patients With Head and Neck Cancer: A Systematic Review

Head &Neck, EarlyView.
ABSTRACT Background Patients with head and neck cancer (HNC) are at risk of impaired muscle health due to metabolic disturbances, reduced nutritional intake, and treatment‐related toxicities. Because muscle health supports physical capacity and independence, its decline may affect quality of life (QoL).
Tycho Zuijlen, Lina van Lint, Christian Preissner, Remco de Bree, Caroline M. Speksnijder   +4 more
wiley   +1 more source

Sarcopenia in the elderly [PDF]

Family Practice, 2012
Sarcopenia is the age-related loss of muscle. It leads to loss of muscle power, which in the end results in frailty and disability. There are numerous causes of sarcopenia. Treatment consists of resistance exercise and a leucine-enriched essential amino acid protein supplement. There is an emerging role for testosterone and other anabolic steroids.
openaire   +2 more sources

Sarcopenia: revised European consensus on definition and diagnosis [PDF]

, 2018
Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia.
Cruz-Jentoft, Alfonso J., Bauer, Jürgen,, Bruyère O, Zamboni M, Topinkova E, Schneider, Stephane M., Bauer J, Sayer, Avan Aihie,, Cooper, Cyrus,, Vandewoude, Maurits,, Bauer, Juergen, Schneider SM, Bauer, Jürgen, Sieber, Cornel C., Vandewoude, Maurits, Schneider, Stephane M.,, Topinkova, Eva,, Landi, Francesco,, Visser, Marjolen, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2, Boirie Y, Rolland, Yves, THE EXTENDED GROUP FOR EWGSOP2, Bruyere, Olivier,, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2., Bruyère, Olivier, Cederholm T, Boirie, Yves,, Topinkova, Eva, Cederholm, Tommy,, Zamboni, Mauro, Sieber, Cornel, Bahat, Gülistan, Cruz-Jentoft AJ, Vandewoude M, Landi, Francesco, Bahat, Gülistan,, Bahat G, Sieber, Cornel C, Rolland, Yves,, Cruz-Jentoft, Alfonso J.,, Boirie, Yves, Cooper, Cyrus, Rolland Y, Visser, Marjolein,, Cruz-Jentoft, Alfonso J, Visser M, Sayer, Avan Aihie, Cederholm, Tommy, Sieber CC, Zamboni, Mauro,, Schneider, Stéphane M, Schols, Jos, Sieber, Cornel C.,, Cruz-Jentoft, Alfonso Jose, Cooper, C., THE EUROPEAN WORKING GROUP ON SARCOPENIA IN OLDER PEOPLE 2 (EWGSOP2), Pitkälä, Kaisu Hannele, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), & the Extended Group for EWGSOP2, Maggio M, Visser, Marjolein, Sayer AA, Landi F, Cooper C, Bautmans, Ivan, Rizzoli R., SIEBER, C.C., Cooper C., Baeyens, Jean Pierre, Martin F., VISSER, M., Schols J., ROLLAND, Y, TOPINKOVA, E., ZAMBONI, M., CRUZ-JENTOFT, J, Maggio, Marcello, Cederholm, T,, Landi F., Reginster, Jean Yves, FINBARR, M., RIZZOLI, R., Sayer, AA, Sánchez-Rodríguez, Dolores, Cederholm T., MAGGIO, M., BAEYENS, J.P., Cherubini, Antonio, Cruz-Jentoft A. J., Sanchez Rodriguez, Maria Dolores Carmen, Michel J. -P., Topinkova E., PITKALA, K., Alfonso J. Cruz-jentoft, Sanchez-Rodriguez D., Baeyens J. -P., Bruyere O., Sayer A. A., Gielen, evelien, CEDERHOLM, T, Schneider S. M., Tournoy, jos, Cooper, C, Zamboni M., Martin, Finbarr, Quiñonez Cabezas, Kevin Antonio, Visser M., BOIRIE, Y, Cruz-Jentoft, AJ, SCHNEIDER, M, CHERUBINI, A., Cesari M., Durán García, Carlos Mario, Baeyens, Jean-Pierre, LANDI, F, Rizzoli, René, Pérez Rayo, Juana Alexandra Janeth, Rolland Y., Pitkala K., Reginster J. -Y., Cesari, Matteo, Kanis J., Bahat G., SCHOLS, J., Bautmans I., Boirie Y., Dedeyne, lenore, BAUER, J, BAUTMANS, I., Vandewoude M., Cherubini A., Visser, Marjolein; id_orcid, Maggio M., Dupont, Jolan, VANDEWOUDE, M., Bruyere, O, KANIS, J., BAHAT, G, Sieber C. C., Bauer J., Pitkala, Kaisu, Michel, Jean-Pierre, SAYER, A.A., CESARI, M., MICHEL, J.P., Reginster, Jean-Yves, Kanis, John, Michel, Jean Pierre   +147 more
core   +1 more source

Sarcopenia: Technological Advances in Measurement and Rehabilitation

, 2021
Sarcopenia is an important recently defined disease affecting people aged ≥65 years all over the world. Improving the assessment of loss of muscle mass is becoming mandatory. In this regard, various new technologies have been advanced.
Grazia D’Onofrio, Daniele Sancarlo, Luigi Esposito, Grazia D'Onofrio, Letizia Lorusso   +4 more
core   +1 more source

Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS

Journal of Cachexia, Sarcopenia and Muscle
Background Sarcopenia, the age‐related loss of muscle mass and function, brings multiple adverse outcomes including disability and death. Several sarcopenia consensuses have newly introduced the premorbid concept of possible sarcopenia and recommended ...
Ya‐Xi Luo, Xiao‐Han Zhou, Tian Heng, Ling‐Ling Yang, Ying‐Hai Zhu, Peng Hu, Xiu‐Qing Yao   +6 more
doaj   +1 more source

Energy System for Wearables

Interdisciplinary Materials, EarlyView.
This review systematically summarizes wearable energy systems, including energy demand, key technical challenges, multi‐channel energy harvesting, flexible energy storage and system integration. We discussed multi‐source hybrid energy harvesting and intelligent energy management in detail, emphasizing their roles in system performance and application ...
Yanjiao Teng, Qing He, Xiaofan Chen, Ting Zhu, Shun Wang, Xiaoming Xu, Jianwei Li, Changyuan Guo, Xuanpeng Wang, Seeram Ramakrishna   +9 more
wiley   +1 more source

Sarcopenia

, 2023
During the last decade, sarcopenia has become one of the hottest topics in geriatrics. Sarcopenia is a major challenge in geriatrics due to its association with numerous negative health-related outcomes, such as falls, fractures, disability, loss of ...
Calvani, Riccardo, Tosato, Matteo, Marzetti, Emanuele   +2 more
core   +1 more source

Longitudinal Associations of Oxaliplatin Treatment With Chemotherapy‐Induced Peripheral Neuropathy in Colorectal cancer Survivors up to 2 Years Post‐Treatment

International Journal of Cancer, EarlyView.
ABSTRACT Chemotherapy‐induced peripheral neuropathy (CIPN) is a potentially long‐term consequence of oxaliplatin‐based chemotherapy for colorectal cancer (CRC). Oxaliplatin dosing is based on body surface area (BSA), but lean body mass (LBM) may influence susceptibility to long‐term CIPN.
Nadira R. Querido, Martijn J. L. Bours, Liselot Valkenburg‐van Iersel, Antoinetta J. M. Beijers, Stephanie O. Breukink, Maryska L. G. Janssen‐Heijnen, Eric T. P. Keulen, Joop L. M. Konsten, Judith de Vos‐Geelen, Matty P. Weijenberg, Colinda C. J. M. Simons   +10 more
wiley   +1 more source

Sarcopenia in Cancer Patients

Indonesian Journal of Cancer, 2019
Introduction: Sarcopenia in cancer patients, especially in advanced stage, recently known as an emerging problem. Firstly, sarcopenia is found in elderly patients.
Andree Kurniawan
doaj   +1 more source

Quantitative Methods for User-Centered Sarcopenia Identification and Management

This study aimed to develop a faster and simpler user-centered approach for sarcopenia identification and management using a novel balance sensor system and wearable robots. The study design was a cross-sectional study.
Ma, Xin, Cheng, Clio Yuen Man, Lou, Vivian W.Q., Xi, Ning, Chen, Jiaming   +4 more
core   +1 more source